Omada Health, Inc. OMDA
Medical/Nursing Services · IPO 2025 · data as of November 13, 2026
Omada Health, Inc. (OMDA) is a healthcare company listed in the US with a market value of about $889M. In the twelve months to September 30, 2026 it had revenue of $333M and net income of $14M, a net margin of 4.2%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is financial health (5/5); the weakest is track record (0/5).
Key numbers: a P/E of 36.7, a price to free cash flow of 31.6, a 5-year average ROIC of -5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 1% above the current price.
About Omada Health
Omada Health is listed in the US and classified in medical/nursing services, IPO year 2025. It was profitable in 0 of the last 3 years in our data. It spends 16% of revenue on research and development.
Score: 2.0 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Positive free cash flow
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 3 years
| Fiscal year | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $333M | $260M | $170M | $123M |
| Net income | $14M | -$13M | -$47M | -$68M |
| Free cash flow | $28M | $17M | -$35M | -$50M |
| EPS (diluted) | $0.39 | $-0.35 | $-6.11 | $-9.52 |
| Net margin | 4.2% | -4.9% | -27.8% | -55.0% |
| ROIC | — | -5.2% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 12 analysts is $26.92, 88% above the current price; targets range from $19.00 to $35.00; the consensus rating is “Buy”; expected EPS is $0.58 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Omada Health’s P/E ratio?
About 36.7, based on the last twelve months of diluted earnings per share (forward P/E about 26.4).
Is Omada Health stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 1% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Omada Health pay a dividend?
Not currently.
Is Omada Health a good stock to buy?
We do not give buy or sell advice. Omada Health scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.